ArticleJournal of feline medicine and surgery2026
Treatment rationales and outcomes for cats with lens luxation: 136 eyes (2007-2023).
Article in Journal of feline medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectivesThe aim of the present study was to evaluate outcomes in cats with lens luxation treated with intracapsular lens extraction (ICLE), medical management or transcorneal lens reduction (TCLR), and to investigate the reasoning behind treatment recommendations.MethodsMedical records were retrospectively reviewed to identify cats with lens luxation. Data collected included signalment, examination findings, treatment decision and rationale for treatment, and outcome.ResultsRecords were reviewed for 136 eyes from 115 cats. Male cats (77%) were overrepresented. Of the eyes, 83/136 (61%) were non-visual on presentation. Medical management was initially elected for 79/136 (58%) eyes, enucleation for 32/136 (24%), ICLE for 12/136 (9%) and TCLR for 7/136 (5%), while no treatment was elected for 3/136 (2%) eyes. Two cats were euthanized (2/136 eyes, 1%) and one eye underwent diode laser cyst ablation. TCLR was not successful in any eyes. Of eyes with follow-up, 12/13 (92%) eyes that underwent ICLE as primary or secondary management were visual and normotensive (intraocular pressure [IOP] <25 mmHg), while 19/50 (38%) medically managed eyes were visual and normotensive. However, 33/50 (66%) medically managed eyes were normotensive at last recheck and 17/23 (74%) medically managed eyes that were visual on presentation remained visual at last recheck. Treatment rationale was noted for 94 eyes. Factors cited included visual status (40%), perceived comfort (36%), age or medical history (29%), financial limitations (12%), inability to medicate (10%), other ocular examination findings (9%) and potential risk of feline post-traumatic ocular sarcoma after ICLE (7%).Conclusions and relevanceTCLR does not appear to be a viable treatment modality in cats. Medical management of lens luxation may produce acceptable results for IOP control and retention of vision when ICLE is not possible. Providing cat owners with accurate information about outcomes and financial implications of treatment options for lens luxation is critical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.